Oral + inhaled dual therapy vs oral monotherapy
Serious adverse events. Outcome assessed on day 42 · bronchiectasis
It is very uncertain whether oral + inhaled dual therapy changes serious adverse events. Outcome assessed on day 42 compared with oral monotherapy (very low certainty).
1 finding from 1 review
- OR 0.48 [0.08, 2.87]1 study · 53 participantsVery low